228 related articles for article (PubMed ID: 31620853)
1. Functional and anatomical imaging in pediatric oncology: which is best for which tumors.
Voss SD
Pediatr Radiol; 2019 Oct; 49(11):1534-1544. PubMed ID: 31620853
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
3. Staging and following common pediatric malignancies: MRI versus CT versus functional imaging.
Voss SD
Pediatr Radiol; 2018 Aug; 48(9):1324-1336. PubMed ID: 30078040
[TBL] [Abstract][Full Text] [Related]
4. SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.
Voss SD
Pediatr Radiol; 2023 Jun; 53(7):1443-1453. PubMed ID: 36899268
[TBL] [Abstract][Full Text] [Related]
5. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Uslu L; Donig J; Link M; Rosenberg J; Quon A; Daldrup-Link HE
J Nucl Med; 2015 Feb; 56(2):274-86. PubMed ID: 25572088
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Imaging in Oncology.
Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
[TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
Beadsmoore C; Newman D; MacIver D; Pawaroo D
Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
[TBL] [Abstract][Full Text] [Related]
8. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
[TBL] [Abstract][Full Text] [Related]
9. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
10. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
Wagner LM; Kremer N; Gelfand MJ; Sharp SE; Turpin BK; Nagarajan R; Tiao GM; Pressey JG; Yin J; Dasgupta R
Cancer; 2017 Jan; 123(1):155-160. PubMed ID: 27563842
[TBL] [Abstract][Full Text] [Related]
11. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
[TBL] [Abstract][Full Text] [Related]
12. [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
Gatidis S; Gückel B; la Fougère C; Schmitt J; Schäfer JF
Radiologe; 2016 Jul; 56(7):622-30. PubMed ID: 27306199
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
[TBL] [Abstract][Full Text] [Related]
14. [New challenges and perspectives in nuclear medicine imaging].
Borbély K
Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
[TBL] [Abstract][Full Text] [Related]
15. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
16. Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.
Bakhshi S; Radhakrishnan V; Sharma P; Kumar R; Thulkar S; Vishnubhatla S; Dhawan D; Malhotra A
Radiology; 2012 Mar; 262(3):956-68. PubMed ID: 22357895
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
Dong Y; Zhang X; Wang S; Chen S; Ma C
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974
[TBL] [Abstract][Full Text] [Related]
20. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
